SM T/2026/000230 20170804 US 201662371280 P 20160805 US 201662371274 P 20160805 UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.

223 Grinter Hall, Gainesville, FL 32611, US US

US ABFERO PHARMACEUTICALS, INC.

405 Waltham StreetSuite 353, Lexington, Massachusetts 02421, US US

US BURKE, Steven Keith

c/o Abfero Pharmaceuticals Inc.405 Waltham StreetSuite 353, Lexington, Massachusetts 02421, US US

BERGERON, Raymond J., Jr.

c/o University of Florida Research Foundation Inc.223 Grinter Hall, Gainesville, Florida 32611, US US

MARI, Marco Giovanni

Via Tre Settembre, 154, 47891 Dogana RSM, SM SM

REGIMI DI DOSAGGIO CON ACIDO (S)-4,5-DIIDRO-2-[2-IDROSSI-4-(3,6-DIOSSAEPTILOSSI)FENIL]-4-METIL-4-TIAZOLCARBOSSILICO PER USO NEL TRATTAMENTO DI SOVRACCARICO DI FERRO DOSAGE REGIMENS WITH (S)-4,5-DIHYDRO-2-[2-HYDROXY-4-(3,6-DIOXAHEPTYLOXY)PHENYL]-4-METHYL-4-THIAZOLECARBOXYLIC ACID FOR USE IN TREATING IRON OVERLOAD 20260526 2026000230 17 PCT/17837761.0 20170804 EP WO/3493801 20251231 20170804 20260526 Brevetti EPO